KRRO (Korro Bio) Accounts Payable: $1.96 Mil (As of Mar. 2026)


KRRO Korro Bio Inc KRRO
6 GF Score
Price $14.05
! 5 Warning Signs
View Full Analysis

What is Korro Bio Accounts Payable?

Korro Bio KRRO +2.41% 6 Accounts Payable is $1.96 Mil as of Mar. 2026. GuruFocus rates KRRO with a GF Score™ of 6/100. The stock has 5 warning signs investors should review.

Korro Bio's Accounts Payable for the quarter that ended in Mar. 2026 was $1.96 Mil.

Korro Bio's quarterly Accounts Payable declined from Sep. 2025 ($2.30 Mil) to Dec. 2025 ($1.65 Mil) but then increased from Dec. 2025 ($1.65 Mil) to Mar. 2026 ($1.96 Mil).

Korro Bio's annual Accounts Payable declined from Dec. 2023 ($7.28 Mil) to Dec. 2024 ($3.99 Mil) and declined from Dec. 2024 ($3.99 Mil) to Dec. 2025 ($1.65 Mil).

Korro Bio Accounts Payable Historical Data

* Premium members only.

The historical data trend for Korro Bio's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Korro Bio Accounts Payable Chart

Korro Bio Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
0.79 2.61 7.28 3.99 1.65

Korro Bio Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.18 5.16 2.30 1.65 1.96
KRRO
6GF Score
Korro Bio Inc KRRO
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Korro Bio Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $1.96 Mil mean?
Korro Bio (KRRO) has a Accounts Payable of $1.96 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Korro Bio and its competitors.
Is Korro Bio's Accounts Payable too high?
Korro Bio's current Accounts Payable is $1.96 Mil. Overall, Korro Bio has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Korro Bio's Accounts Payable compare to LENZ and ANTX?
Korro Bio's Accounts Payable of $1.96 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Korro Bio and its competitors. Korro Bio's current Accounts Payable is $1.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Korro Bio stock overvalued right now?
Korro Bio (KRRO) has a current Accounts Payable of $1.96 Mil. The current Accounts Payable is $1.96 Mil. Korro Bio's overall GF Score™ is 6/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Korro Bio (KRRO), the current Accounts Payable is $1.96 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Korro Bio Business Description

Address 60 First Street, 2nd Floor, Suite 250, Cambridge, MA, USA, 02141
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
6GF Score

Get the complete analysis for KRRO

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.05
Price